Latest California Healthline Stories
Justice Department Joins Lawsuit Alleging Massive Medicare Fraud By UnitedHealth
The Department of Justice is joining a whistleblower lawsuit in a fraud case against UnitedHealth in which damages could top $1 billion.
House Leaders Came Up Short In Effort To Kill Obamacare
Trump and Speaker Ryan agree to withdraw their legislation that would overhaul the federal health law.
Popular Guarantee For Young Adults’ Coverage May Be Health Law’s Achilles’ Heel
Republicans and Democrats don’t agree on much these days, but both parties want to keep the health law’s provision to allow adults to stay on their parents’ plan until age 26. But that could be hurting the marketplace’s insurance pools.
Late Move To Dump ‘Essential’ Benefits Could Strand Chronically Ill
Republicans seek lower cost and more choice for health insurance sold to individuals, but cutting coverage standards could leave fewer comprehensive plans, analysts say.
From ‘Stressed Out’ To Hopeful, Five Californians Weigh In On GOP Bill
The Republicans’ health care plan, which would generally reduce premium subsidies and limit federal funding for Medicaid, has many Californians wondering what will happen to their coverage. We spoke with some of them.
As health care issues hit center stage in Washington again, Kaiser Health News reporters hold forth on a number of radio and television shows.
How Millennials Win And Lose Under The GOP Health Bill
The cost of insurance could go down for people ages 26 to 29 under the GOP plan. But will they buy it without a mandate?
Low-Income AIDS Patients Fear Coverage Gains May Slip Away
The federal health law made it feasible for the AIDS Drug Assistance Program to expand its efforts and help patients buy marketplace insurance plans to cover drugs and other health care.
Trump’s Promise To Rein In Drug Prices Could Open Floodgate To Importation Laws
Sen. Bernie Sanders’ bill to allow Americans to buy cheaper medicines from Canada would bypass a requirement that blocked past legislative efforts over two decades.
GAO To Launch Investigation Of FDA’s Orphan Drug Program
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.